(Q87313825)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24543599%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

title

Oral triethylene melamine therapy in human neoplastic disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24543599%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author name string

E K BLACKBURN

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24543599%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

G M KING

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24543599%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

publication date

1 October 1954

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24543599%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24543599%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24543599%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

page(s)

96-103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24543599%20AND%20SRC:MED&resulttype=core&format=json

Clinical observations on the use of triethylenemelamine

8 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0368-2242%2854%2980060-1

7 January 2021

Clinical use of triethylene melamine; report of seventy-five cases

1 reference

https://api.crossref.org/works/10.1016%2FS0368-2242%2854%2980060-1

7 January 2021

Triethylene melamine in the treatment of lymphomas and other neoplastic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0368-2242%2854%2980060-1

7 January 2021

Dermatitis due to triethylene melamine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0368-2242%2854%2980060-1

7 January 2021

Triethylene melamine in clinical cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0368-2242%2854%2980060-1

7 January 2021

Triethylene melamine therapy in Hodgkin's and other malignant diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0368-2242%2854%2980060-1

7 January 2021

Triethylene melamine in the treatment of neoplastic disease; a compound with nitrogen-mustardlike activity suitable for oral and intravenous use

1 reference

https://api.crossref.org/works/10.1016%2FS0368-2242%2854%2980060-1

7 January 2021

Triethylene melamine in human malignant disease; results with oral administration of enteric-coated tablets.

1 reference

https://api.crossref.org/works/10.1016%2FS0368-2242%2854%2980060-1

7 January 2021

Treatment of polycythemia vera with triethylene melamine; summary of thirty cases

1 reference

https://api.crossref.org/works/10.1016%2FS0368-2242%2854%2980060-1

7 January 2021

Use of triethylene melamine in treatment of leukemia and leukosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0368-2242%2854%2980060-1

7 January 2021

10.1016/S0368-2242(54)80060-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24543599%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference